{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System",
        "BD Phoenix\u2122 Automated Microbiology System for use with Ciprofloxacin (0.25-4 \u03bcg/ml) - Gram-negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K052269",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020321",
        "K020323",
        "K020322",
        "N50510",
        "K023895"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "August 17, 2005",
    "Summary Letter Received Date": "August 19, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ciprofloxacin",
        "Citrobacter koseri",
        "Citrobacter freundii",
        "Enterobacter cloacae",
        "Escherichia coli",
        "Klebsiella pneumoniae",
        "Morganella morganii",
        "Proteus mirabilis",
        "Proteus vulgaris",
        "Providencia rettgeri",
        "Providencia stuartii",
        "Pseudomonas aeruginosa",
        "Salmonella typhi",
        "Serratia marcescens",
        "Shigella boydii",
        "Shigella dysenteriae",
        "Shigella flexneri",
        "Shigella sonnei",
        "Acinetobacter lwoffi",
        "Aeromonas hydrophila",
        "Edwardsiella tarda",
        "Enterobacter aerogenes",
        "Klebsiella oxytoca",
        "Salmonella enteritidis",
        "Yersinia enterocolitica"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates",
        "Aerobic Gram-negative bacteria",
        "Facultative anaerobic bacteria",
        "Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution test",
        "Automated antimicrobial susceptibility testing",
        "Redox indicator detection",
        "Bacterial turbidity measurement"
    ],
    "Methodologies": [
        "Microdilution",
        "Minimal inhibitory concentration determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System with ciprofloxacin panels for automated antimicrobial susceptibility testing of Gram-negative and Gram-positive bacteria",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative aerobic and facultative anaerobic bacteria isolates and most Gram-positive bacteria isolates from pure culture",
    "fda_folder": "Microbiology"
}